相关实验视频
Updated: Jul 23, 2025

08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
1.7K
对接受维持血液透析的患者进行额外的输血:回顾性分析
Wendong Li1, Jing Wang1, Yanqin Wang1
1Department of Nephrology, Baoji People's Hospital Baoji 721000, Shaanxi, China.
American journal of translational research
|July 12, 2023
概括
血液透析与输血和针相结合,改善了慢性病患者的和代谢和免疫功能. 这种联合疗法有效地管理完整的副甲状腺激素 (iPTH) 水平,而不会对营养状况产生负面影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
- 生物化学 生物化学
背景情况:
- 和代谢障碍 (CPMD) 是接受维护血液透析的患者常见的并发症.
- 完整的副甲状腺激素 (iPTH) 和营养状况是患者结果的关键指标.
研究的目的:
- 评估在维护血液透析患者中,结合血液透析与血液输液和针治疗CPMD的疗效.
- 评估这种联合治疗对iPTH水平和营养状况的影响.
主要方法:
- 对142名接受维持血液透析的患者进行了回顾性分析.
- 对照组 (血液透析+针) 和研究组 (血液透析+输血+针) 的比较.
- 评估生化标志物 (iPTH,Ca,P,-产物,β2-MG,Scr,BUN),免疫功能 (IgG,IgM) 和营养指标 (Alb,PA,Hb). 评估生化标志物 (iPTH,Ca,P,-产物,β2-MG,Scr,BUN),免疫功能 (IgG,IgM),以及营养指标 (Alb,PA,Hb). 评估生化标志物 (iPTH,Ca,P,产物,β2-MG,Scr,BUN) 和营养指标 (Alb,PA,Hb).
- 使用 LASSO 回归的风险预测模型的开发.
主要成果:
- 与对照组相比,研究小组在治疗后显著降低了P,iPTH和-产品,并且与对照组相比,治疗后的Ca水平更高 (P<0.05).
- 输血组合导致降低β2-MG,Scr,BUN,并改善了Alb水平 (P<0.05).
- 研究小组观察到增强的免疫功能 (IgG,IgM);营养标志物保持稳定,与控制组不同,它们下降 (P<0.05).
- 一个风险评分模型显示了治疗疗效的高预测准确性 (AUC=0.991).
结论:
- 血液透析与输血和针相结合,有效调节免疫功能和-代谢,包括增加血液中的.
- 这种联合治疗不会对患者的营养状况产生不利影响.
- 该研究开发了一个基于关键临床参数的治疗疗效的预测模型.
相关概念视频
Hemodialysis III: Nursing Management
50
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
50
Hemodialysis II: Procedure and Complications
42
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
42
Hemodialysis I: Introduction
57
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
57
Dialysis
369
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
369
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
44
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
44
Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54

